南華早報Editorial | The real test begins for Hong Kong’s new drug regulator
署名 SCMP Editorial全文約 4,193 字
文章摘要
南華早報 · 文章頁摘要Under its new chief, the Centre for Medical Products Regulation must quickly assemble the expertise needed to bridge local strengths with the mainland’s pharmaceutical power.
A number of important things must fall into place to flesh out a vision of Hong Kong as a biotech hub with a key role in developing affordable access...